Inquire About a Product| Product: | Trimetazidine-d8 DiHCl | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D4485 | ||||||||
| CAS Number: | 1219795-37-5 | ||||||||
| Synonyms: |
(1-[(2,3,4-Trimethoxy-phenyl)methyl]piperazine-D8 Dihydrochloride); Trimetazidine-d8 DiHCl (piperazine-d8) |
||||||||
| Pricing: |
|
||||||||
| Enrichment: | 98%D | ||||||||
| Molecular Weight: | 347.31 | ||||||||
| Structure: |
|
||||||||
| Category: | Heterocyclic Compounds | ||||||||
| Literature References: |
Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A ., A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J. Am. Coll. Cardiol., 2006, Sep., 48 (5): 992–8.; Tuunanen H, Engblom E, Naum A, Någren K, Scheinin M, Hesse B, Juhani Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J., Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation, 2008, Sep, 118 (12): 1250–8. |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled cytoprotective anti-ischemic agent. Used to treat angina pectoris. Improves myocardial glucose utilization by inhibiting fatty acid metabolism. Also can be used to treat tinnitus and dizziness. |